!!Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
Blazar, B. R. (PI), Felices, M. (PI), Luo, X. (PI), Miller, J. S. (PI), Osborn, M. J. (PI), Rao, J. S. (PI), Wagner, J. E. (PI), Bachanova, V. (CoI), Betts, B. (CoI), Brunstein, C. G. (CoI), Cichocki, F. M. (CoI), De For, T. E. (CoI), Eaton, A. (CoI), Hippen, K. L. (CoI), Maakaron, J. (CoI), McKenna, D. H. (CoI), Shanley, R. M. (CoI), Tolar, J. (CoI), Zaiken, M. C. (CoI), Dougherty, P. R. (Graduate Student), Peng, Y. (Graduate Student), Le, C. T. (Prior Principal Investigator), Braun, J. A. (Other Role), Cao, Q. (Other Role), Dasgupta, T. (Other Role), Hinderlie, P. (Other Role), Jin, D. D. (Other Role), Kennedy, P. (Other Role), Kile, Q. (Other Role), Kopp, B. (Other Role), Lenvik, T. R. (Other Role), Meyer, C. M. (Other Role), Phung, G. (Other Role), Ramesh, V. (Other Role), Sleeth, M. L. (Other Role), Soignier, Y. M. (Other Role) & Xia, L. H. (Other Role)
5/5/23 → 4/30/28
Project: Research project
-
Pediatric Ohio-New York Cancer (Peds-ONC) Immunotherapy Center
Miller, J. S. (PI), Moriarity, B. S. (PI) & Soignier, Y. M. (Other Role)
NATIONWIDE CHILDREN'S HOSPITAL, NIH NATIONAL CANCER INSTITUTE
9/12/19 → 8/31/25
Project: Research project
Research output
- 7 Article
-
Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to induce cytotoxicity
Dixon, K. J., Hullsiek, R., Wang, S., Friess, R. R., Matson, A. W., Soignier, Y., Lenvik, A. J., Wu, J., Hart, G. T., Felices, M. & Walcheck, B., 2026, In: Frontiers in immunology. 17, 1714022.Research output: Contribution to journal › Article › peer-review
Open Access3 !!Link opens in a new tab Scopus citations -
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer
Phung, S. K., Zorko, N. A., Soignier, Y., Waller, R. L., Shackelford, M., Walker, J. T., Nelson, T. D., Selleck, C., Bendzick, L. E., Kotz, L. E., Kile, Q. M., Bozicevich, A. J., Miller, S. E., Khaw, M., Shetty, M., Hinderlie, P., Ehrhardt, M., Li, Y., Luo, X. & Dehm, S. M. & 4 others, , Feb 1 2025, In: Cancer Immunology Research. 13, 2, p. 258-272 15 p.Research output: Contribution to journal › Article › peer-review
Open Access10 !!Link opens in a new tab Scopus citations -
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer
Khaw, M. J., Zorko, N. A., Kennedy, P. R., Bendzick, L. E., Shackelford, M., Selleck, C., Hinderlie, P., Walker, J. T., Soignier, Y., Lyons, R. C., Femino, E. L., Stenger, T., Dasgupta, T., Kotz, L. E., Shetty, M., Phung, S. K., Lee, E. H., Lu, Q., Lim, J. & Provenzano, P. P. & 7 others, , Jul 23 2025, In: Journal for ImmunoTherapy of Cancer. 13, 7, e011370.Research output: Contribution to journal › Article › peer-review
Open Access13 !!Link opens in a new tab Scopus citations -
Effect of camelid B7-H3 tri-specific killer engagers on natural killer cells in patients with prostate cancer
Zorko, N., Shackelford, M., Bozicevich, A., Walker, J., Hinderlie, P., Phung, G., Khaw, M., Rugloski, J., Russell, A., Soignier, Y., Kotz, L., Bendzick, L., Hwang, J., Antonarakis, E. S., Felices, M. & Miller, J. S., 2024, In: Journal of Clinical Oncology. 42, 4, 155.Research output: Contribution to journal › Article › peer-review
2 !!Link opens in a new tab Scopus citations -
TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity
Kaminski, M. F., Bendzick, L., Hopps, R., Kauffman, M., Kodal, B., Soignier, Y., Hinderlie, P., Walker, J. T., Lenvik, T. R., Geller, M. A., Miller, J. S. & Felices, M., Sep 26 2022, In: Journal for ImmunoTherapy of Cancer. 10, 9, e004725.Research output: Contribution to journal › Article › peer-review
Open Access22 !!Link opens in a new tab Scopus citations